August 30, 2023 – Chicago, IL – Respiratory Health Association is proud to announce the election of Dr. Meenal B. Patwardhan, MD, MHSA, to its Board of Directors. Dr. Patwardhan’s extensive experience in academia, evidence-based practice, healthcare policy, as well as her leadership in the pharmaceutical industry and expertise in clinical research make her a valuable addition to the Board. Dr. Patwardhan’s appointment reinforces RHA’s commitment to excellence, innovation, and collaboration. Her leadership and strategic insights will play a crucial role in shaping the organization’s future initiatives and driving positive change in the field of lung health.
“As a member of the RHA Board of Directors, I look forward to enabling rigorous research and policy-making that will positively impact the lives of so many patients, like myself, who deal with lung conditions.”
“Dr. Patwardhan’s clinical expertise and leadership is a welcome addition to RHA’s Board of Directors,” said Joel Africk, RHA President and CEO. “We are excited to work with her in our ongoing fight against lung disease to support families, patients, and caregivers.”
Dr. Patwardhan brings a wealth of knowledge and a proven track record of success in various leadership roles. With over 15 years of experience in the pharmaceutical industry, including positions at Abbott/AbbVie, she has demonstrated her ability to lead and motivate large national and international teams. Her expertise in evidence-based medicine, outcomes research, and healthcare decision-making will be instrumental in shaping the strategic direction of RHA.
Additionally, Dr. Patwardhan’s tenure as Adjunct Associate Professor of Medicine at Duke University Medical Center highlights her dedication to education and research. She has contributed significantly to the field of medicine through her research endeavors, clinical trial design, and implementation of evidence-based practices.